Glaucoma is a disease characterized by fluid builds up in the front part of your eye which results in damages to the eye’s optic nerve which may lead to blindness if left untreated.Open angle glaucoma (OAG) is the most common type of glaucoma followed by closed angle glaucoma (CAG) and these two account for greater than 50% of glaucoma cases.Browse Sample of the Report @ The market for glaucoma is increasing at an impressive rate primarily driven by the growing number of geriatrics.The last decade has seen impressive additions to the surgery options such as laser therapy, photodynamic therapy etc.The market constraints are excellent efficacy and efficiency of present drugs especially prostaglandin analogs and carbonic anhydrase inhibitors, which has set the bar for a new therapy extremely high and the loss of patent protection on the major drugs used to treat glaucoma.Taking all factors into consideration, we expect the Asia Pacific glaucoma treatment market to reach around $ 888.94 million in 2023 from $576.0 million in 2017, by the end of the forecast period at a CAGR of ~ 7.5 %.While the glaucoma drug market will grow by a flat CAGR of 2.1% the glaucoma surgery market is poised for an explosive CAGR of 18.5 %.Key Players for Asia-Pacific Glaucoma Treatment Market:Some of the key players in this market are: Novartis AG, Pfizer Inc., Allergan, Merck & Co., Ocular Therapeutix Inc, pSivida Corp, Icon Bioscience Inc, Amorphex Therapeutics LLC., Ellex, Quantel, Lumenis, and Lightmed among others.Segments:Asia-Pacific Glaucoma Treatment Market has been segmented on the basis of disease indication which comprises Closed Angle Glaucoma (CAG), open angle glaucoma (OAG), secondary glaucoma, congenital glaucoma and other.
According to IMARC Group’s latest report, titled “Adhesion Barriers Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,” the market to reach register a CAGR of around 6% during 2020-2025.Adhesion barriers are medical implants that are utilized to reduce post-surgical internal scarring by separating the tissues and organs.They assist in lowering common risks, such as chronic pain, infertility and bowel obstruction, during different surgeries.At present, they are available in the form of gel, film and liquid formulations across the globe.Request for a free sample copy of this report: TrendsThe increasing prevalence of chronic diseases, coupled with the rising number of surgical procedures, represents one of the key factors impelling the global adhesion barriers market growth.Furthermore, the rising number of sports-related injuries and the rising geriatric population are further bolstering the market growth.Several medical associations are spreading awareness about post-surgical adhesion formation and available products, such as adhesion barriers, which is acting as another major growth-inducing factor.Other factors, such as rising healthcare investments and the advent of the sheet- and spray-type adhesion barriers that are more effective and convenient to use during laparoscopic procedures, are expected to drive the market growth in the upcoming years.Adhesion Barriers Market 2020-2025 Analysis and Segmentation:The report has segmented the market on the basis of product, formulation, application and region.Breakup by Product:SyntheticNatural Breakup by Formulation:Film FormulationsLiquid FormulationsGel Formulations Breakup by Application:Gynecological SurgeriesGeneral/Abdominal SurgeriesCardiovascular SurgeriesOrthopedic SurgeriesNeurological SurgeriesReconstructive SurgeriesUrological SurgeriesOthersExplore full report with table of contents: by Region:North AmericaUnited StatesCanadaAsia PacificChinaJapanIndiaSouth KoreaAustraliaIndonesiaOthersEuropeGermanyFranceUnited KingdomItalySpainRussiaOthersLatin AmericaBrazilMexicoOthersMiddle East and AfricaCompetitive Landscape:The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.Some of these key players include:Anika Therapeutics Inc.Atrium Medical CorporationBaxter InternationalBetatech MedikalC.
27th Jan 2021 - The global Aminoglycosides Market is estimated to touch US$ 1.68 billion by the completion of the prediction period.The market was appreciated by above US$ 1.1 billion in the year 2014.It is estimated to develop at a CAGR of 3.5% for the duration of the prediction.Growing frequency of bacteriological contaminations instigated by gram-positive and gram-negative microorganisms are the other driving factors.Additionally, this category of antibiotics is effective even after bacteriological inoculum is outsized, and is regularly utilized as a subsequent stroke of protection in contradiction to simple contamination.The Aminoglycoside market on the source of Type of Application could span Neonatal Sepsis, Respiratory, Veterinary, UTI & Pelvic Disease, Skin.The usage of aminoglycosides for breathing contaminations for example tuberculosis responsible for the extreme stake of income during the year 2014 due to greater occurrence of tuberculosis in the emerging provinces throughout the world drives the market.The Aminoglycosides market on the source of Type of Management could span Oral, Intra-mammary, Feed, Topical, Injectable [Parenteral].Access Aminoglycosides Market Report with TOC @ Product Outlook (Market Revenue in USD Million, 2012 - 2022 )NeomycinTobramycinGentamicinAmikacinParomomycinStreptomycinKanamycinOthers Aminoglycoside Outlook, by Route of Administration (Market Revenue in USD Million, 2012 - 2022)InjectablesFeedIntra-mammaryTopicalOral Aminoglycoside Application Outlook (Market Revenue in USD Million, 2012 - 2022)VeterinarySkin InfectionRespiratory diseasesUTI & Pelvic DiseasesOther diseases Some of the important companies operating in the field on international basis are Medico Remedies Pvt.
27th Jan 2021 - The global Medical Sensors Market is anticipated to cross USD 18.5 billion by 2024.Medical sensors market is highly driven by rise in prevalence of chronic diseases and demand for better healthcare services owing to rise in high quality diagnostic and monitoring devices.In addition, technological breakthroughs in medical science and rise in R for digital devices that enable data capturing and storage are likely to help in market progress.By application, the medical sensors market is segmented as patient monitoring, diagnostics and therapeutics.Patient monitoring is fragmented into cardiac monitoring electrode, pulse oximeter, continuous blood glucose monitoring, and continuous blood pressure monitoring.Diagnostics is quadfurcated into HIV test strip sensors, pregnancy test strip sensors, blood glucose test strip sensors, capsule endoscopes, and immunoassay biosensors.Therapeutics segmented as dialysis sensors, cardiac catheter sensors, insulin pump sensors and cardiac therapeutic electrode sensors.Access Medical Sensors Market Report with TOC @ type is further segmented as implantable sensors, ingestible sensors, strip sensors, wearable sensors, and implantable sensors.
The Global Myasthenia Gravis Disease Market is anticipated to exceed USD 2,538.6 Million by 2026 according to a new research published by Polaris Market Research.Myasthenia gravis disease is characterized by rapid fatigue and weakness of any muscles under person’s voluntary control.In General, myasthenia gravis disease is caused by a breakdown in the normal communication between muscles and nerves.There is no accurate cure for MG disease, however, appropriate and early treatment can help to control symptoms, such as double vision, difficulties with speech, chewing, swallowing and breathing, weakness of arm or leg muscles, and drooping of eyelids.The global Myasthenia Gravis Disease market is majorly driven by the need to prevent declining quality of life owing to myasthenia gravis disease.In addition, key players are also involved in innovative research to launch the affordable therapeutics for such disease.The imaging segment is further bifurcated into X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and others.
The global gout therapeutics market size is expected to reach USD 6,304.8 million by 2026 according to a new study by Polaris Market Research.The report “Gout Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Non-steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Colchicine, Urate Lowering Agents) Disease Condition (Acute, Chronic); By Regions, Segments & Forecast, 2020 – 2026” gives a detailed insight into current market dynamics and provides analysis on future market growth.The incidence of gout has witnessed continual growth over the past years.It is majorly caused by uncontrolled metabolic disorder and high level of uric acid in the body.U.S. region is observed to have a high prevalence of gout owing to lifestyle issues such as high alcohol intake, obesity, and smoking resulting in the inflammatory disorder.Attributed to these factors along with the adoption of innovative treatments and increased understanding about arthritic conditions, the market in North America region is observed to be the dominant market across all regions during 2018.Request for sample copy of this report @ per the severity of gout condition recommendations of medications and therapies are made to the respective patients.
Infectious Disease Therapeutics market is segmented by Type, and by Application.Players, stakeholders, and other participants in the global Infectious Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource.The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.Also Read: key players covered in this studyNovartis AGGileadGlaxoSmithKline plcJanssen Pharmaceutical Inc.Hoffmann-La Roche Ltd.BioCryst Pharmaceuticals Inc.Merck & Co. Inc.Boehringer Ingelheim GmbHAlso Read: segment by Type, the product can be split intoDrugsVaccinesAlso Read: segment by Application, split intoHIV/AIDSInfluenzaHepatitisMalariaTuberculosisOthersAlso Read: segment by Regions/Countries, this report coversNorth AmericaEuropeChinaJapanSoutheast AsiaIndiaCentral & South AmericaAlso Read:
Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions Roots Analysis is pleased to announce the publication of its recent study, titled, “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019–2030.” The report features an extensive study of the current landscape and future outlook of the immuno-oncology biomarkers testing market (focusing particularly on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+)).It provides an in-depth analysis, highlighting the capabilities of the various companies engaged in this domain.Amongst various elements, the report includes:A detailed analysis of ongoing, biomarker-based clinical trials initiated by big pharmaceutical companies.An analysis of the landscape of companies offering testing services for cancer biomarkers, namely TMB, MSI / MMR and TILs (including CD3+, CD4+, CD8+ and FOXP3+).An insightful 2X2 representation of the results of a detailed competitiveness analysis of various tests (segregated across different biomarker groups).Elaborate profiles of leading analytical testing service providers focused on immuno-oncology biomarkers (shortlisted based on strength of service portfolio).A detailed publication analysis of over 180 research articles that have been published since 2016, highlighting the key focus areas of ongoing research activity related to immuno-oncology biomarkers, namely TMB, MSI / MMR and TILs.A comprehensive clinical trial analysis of completed, ongoing and planned studies, focused on the assessment of cancer biomarkers, namely TMB, MSI / MMR and TILs.A discussion on the upcoming opportunities that are likely to impact the evolution of this market over the coming years.A discussion on various steps involved in development operations of companion diagnosticsA comparative analysis of the needs of different stakeholders involved in the development of companion diagnostic productsA detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)Type of testLaboratory Developed Tests (LDTs)Companion Diagnostic Tests (CDx)Type of disease indicationBreast cancerBlood cancerColon / Colorectal cancerLung CancerMelanomaProstate CancerType of cancer biomarkerTMBMSI / MMRTILsType of analytical techniqueNext Generation Sequencing (NGS)Polymerase Chain Reaction (PCR)Immunohistochemistry (IHC)Others Key geographical regionsNorth AmericaEuropeJapanChinaAustralia  Key companies covered in the reportFoundation MedicineNeoGenomics LaboratoriesNovogeneQ2 SolutionsPersonal Genome DiagnosticsDr Lal PathLabsShenzhen Yuce Biotechnology For more information please click on the following link: Other Recent OfferingsGlobal T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019-2030Neoantigen Targeted Therapies Market, 2019-2030Companion Diagnostics Market (2nd Edition), 2019-2030Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030In Vitro ADME Testing Services Market, 2019-2030 About Roots AnalysisRoots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry.The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.If you’d like help with your growing business needs, get in touch at [email protected] Contact InformationRoots Analysis Private LimitedGaurav Chaudhary+1 (415) 800 [email protected]
The global bacteriophage market was valued at US$ 567.9 Mn in 2017 expanding at a CAGR of 3.9% from 2018 to 2026.Market InsightsRecently, bacteriophages or phages have been recognized as an efficient tool in modern biotechnology through a multitude of researches promoting the potential use of bacteriophages across a number of applications.They can also be used as biocontrol agents in the oil and agriculture industries.Bacteriophages have a unique application in the petroleum industry, as bacterial fouling often leads to serious damage to gas pipelines, devaluing products and therefore increasing capital costs.Bacteriophages are a diverse group of viruses that can be easily manipulated and therefore have a significant role to play in research, therapeutics and biotechnology.Phages not only control the bacterial population, but also help to move genes from one bacterium to another.Globally, the incessant increase in bacterial resistance to most antibiotics is becoming a new driving factor for phage therapy that uses lytic phage particles because these entities are devoid of metabolic functioning and do not have an affinity to eukaryotic cells.Moreover, established use of bacteriophages in the areas of environment and food and evolved research infrastructure with several initiatives being undertaken introducing breakthrough technologies will further drive the market during the forecast period.The key players currently engaged in bacteriophage market include Federal State Scientific Industrial Company MICROGEN, AmpliPhi Biosciences Corporation, EnBiotix, Phage Biotech Ltd., Fixed-Phage Limited, InnoPhage, Pherecydes Pharma, TechnoPhage SA, VersatileBio among others.Key Market Movements:Growing R and funding for investigating bacteriophage therapy for clinical application • Ongoing clinical trials for bacteriophage therapy for multidrug resistant bacterial infections and regulatory approvals for the same • Increasing applications of bacteriophage in food, environment and veterinary applications • Ongoing research for establishing bacteriophage as an effective vaccine delivery systemGet Sample Copy of This Report With Covid19 Impact Analysis: ToC:Chapter 1.
Artificial Intelligence in Medical imaging can be described as the diagnostic procedure that involves the creation of visual aids and image representations of the human body, and involves the monitoring of performance and functioning of the organs of the human body.With the integration of artificial intelligence (AI) in healthcare and medical imaging, there is a change in the way the diagnostics and the entire procedure is carried out.The AI assists the surgeons in carrying out the image capturing process and how to diagnose these images for the conclusion and personalized treatment in respect to every individual and patient.Artificial intelligence mainly consists of two types, robots and machine learning.Machine learning involves the recognition and application of algorithm in computer systems for the rendering of images.Whereas, robots are engaged in the assistance of patients, doctors and operators in the visualization and diagnostic procedures.Global Artificial Intelligence in Medical Imaging Market of which artificial intelligence in medical imaging is a part of is expected to rise from its initial estimated value of USD 21.48 billion in 2018 to a projected value of USD 264.85 billion by 2026, registering a CAGR of 36.89% in the forecast period of 2019-2026.Get a Sample Copy of Global Artificial Intelligence in Medical Imaging market Report to Understand the Complete Insights @ Drivers and Restraints:Increased numbers of diagnostic procedures carried out is expected to drive the market growthAbility and achievement of personalized treatment, improved procedures and treatment of the patients are also expected to drive the market growthLack of integration and practical applications of artificial intelligence is expected to restrain the market growthHigh cost and reluctance of adoption of these systems is also expected to restrain the market growthThe major players covered in the Artificial Intelligence in Medical Imaging Market Major competitors currently present in the market are BenevolentAI, OrCam, Babylon, Freenome Inc., Clarify Health Solutions, BioXcel Therapeutics, Ada Health GmbH, GNS Healthcare, Zebra Medical Vision Inc., Qventus Inc, IDx Technologies Inc., K Health, Prognos, Medopad Ltd., Inc., Voxel Technology, Renalytix AI plc, Beijing Pushing Technology Co. Ltd., PAIGE, mPulse Mobile, Suki AI Inc., BERG LLC, Zealth Inc., OWKIN INC., and Your.MD.Major TOC Of The ReportChapter One:  Artificial Intelligence in Medical Imaging Market OverviewChapter Two: Manufacturers ProfilesChapter Three:  Global Artificial Intelligence in Medical Imaging Market  Competition, by PlayersChapter Four: Global Artificial Intelligence in Medical Imaging Market Size by RegionsChapter Five: North America Artificial Intelligence in Medical Imaging Market Revenue by CountriesChapter Six: Europe Artificial Intelligence in Medical Imaging Market Revenue by CountriesChapter Seven: Asia-Pacific Artificial Intelligence in Medical Imaging Market Revenue by CountriesChapter Eight: South America Artificial Intelligence in Medical Imaging Market Revenue by CountriesGet Detailed Table of Contents @ Report HighlightsComprehensive pricing analysis based on different product types and regional segmentsMarket size data in terms of revenue and sales volumeDeep insights about regulatory and investment scenarios of the global Artificial Intelligence in Medical Imaging Market    Analysis of market effect factors and their impact on the forecast and outlook of the global Artificial Intelligence in Medical Imaging Market    The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the global Artificial Intelligence in Medical Imaging Market    A roadmap of growth opportunities available in the global Artificial Intelligence in Medical Imaging Market    with the identification of key factorsThe exhaustive analysis of various trends of the global Artificial Intelligence in Medical Imaging Market    to help identify market developmentsAccess Full Report @ Questions Answered in Report:What is the key to the Artificial Intelligence in Medical Imaging Market?What will the Artificial Intelligence in Medical Imaging Market Demand and what will be Growth?What are the latest opportunities for Artificial Intelligence in Medical Imaging Market in the future?What are the strengths of the key players?About Us:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.
Market Statistic, LLP has recently published a research study about Global Cervical Plates Market.The report illustrates the market thoroughly and has offer a structural evaluation analysis of the market.‘Global Cervical Plates Market comprises of basic market dynamics like the driving and restraining factors, industry trends and growth opportunities in the forecast period (2021-2027).’ The report offers detailed analysis & statistics of the different market segments globally.Get sample pages from this research report @ The leading market players covered in this report are: •Amed Therapeutics•Ulrich medical•NuVasive•Innov'spine•South America Implants•ChM•EUROS•Ackermann Instrumente•BIOTECHNIs The scope of all these distinct segments has been covered in the report and has been researched separately.This is likely to help investors decide where to invest in the right industry segment.Additionally, the research report also offers complete analysis of industry players¬- this comprises extensive company product as well as company profile specifications.
Adrenocortical Carcinoma Treatment Market Overview: Market Research Future (MRFR) announces the publication of its research report -Global Adrenocortical Carcinoma Treatment Market, 2018-2023.It is estimated that the global adrenocortical carcinoma treatment market is expected to grow at a CAGR ~ 2.6 % with a projected market value of 678 million during the forecast period of 2018-2023.ALSO READ : carcinoma (ACC) is a rare and highly aggressive carcinoma.According to the International Pediatric Adrenocortical Tumor Registry, the female-to-male ratio for adrenocortical carcinoma is approximately 2.5-3:1.However, differentiation of benign and malignant tumor in the initial stages needs proper evaluation.These factors coupled with the lack of oncology experts may restrain the growth of the market during the forecast period.ALSO READ : Players: Some of the key players in the global adrenocortical carcinoma market are Pfizer Ltd., Arqule, EnGeneIC Ltd, Exelixis, Inc., Millendo Therapeutics, Inc., Merck & Co., Orphagen Pharmaceuticals, Inc., HRA Pharma, Bristol-Myers Squibb Company, General Electric Company, WG Critical Care, LLC, Mylan N.V., Fresenius Kabi AG, Sinovision Technologies (Beijing) CO. ,Ltd., Hitachi, Ltd., NeuroLogica Corp., and Digirad Corporation.ALSO READ : The global adrenocortical carcinoma treatment market has been segmented into type, therapy, and end-user.The prominent players in this market are involved in new product launches, strategic partnerships to expand their product portfolio.
Global Railway Platform Security Market is expected to register a CAGR of 5.5% during the review period, 2019-2025.Key factors responsible for market growth are the increasing need to minimize the risk of unauthorized access to platforms and the growing demand for additional support and advanced solutions for security management.North America dominated the Railway Platform Security Market with the highest market share, whereas, Asia-Pacific (APAC) is expected to be the fastest-growing region in the railway platform security market, due to the increasing adoption of advanced technologies and increasing GDP of Asia- Pacific countries.ALSO READ : Analysis: The Global Railway Platform Security Market is characterized by the presence of several regional and local providers.Some of the key players in the market are Honeywell (US), IndraSistemas (Spain), Huawei (China), Bosch (Germany), Atos (France), FLIR Systems (US), Axis Communications (Sweden), telent (UK), Zhejiang Dahua (US), Hikvision (China), STANLEY (US), Wabtec (US), L Technology Services (India), Mitsubishi Electric (Japan), Genetec (Canada), Knorr-Bremse (Germany), Nabtesco (Japan), Senstar (Canada), Avnet (US), and Anixter (US) among others.ALSO READ : Analysis: The Global Railway Platform Security Market has been segmented based on Component, Application, and Region.The solutions play an important role in handling all the railway platform security-related activities such as passenger safety and security.Moreover, the solutions are used to improve operational efficiency and railways management systems.The services segment has been divided into professional services and managed services; this segment is expected to record a higher growth rate during the forecast period due to the growing need to improve decision-making and organizational efficiency.
The demand for biologically derived materials for regenerative medicine is currently high due to its efficiency over other naturally derived materials.During the surgical procedures, synthetic materials are more preferred as they provide better outcome.Increase in demand for material reengineering and cell biology with the recent progress in the design of synthetic materials have led to the use of hydrogel in the formation of tissue-engineered scaffolds.ALSO READ : to MRFR, the Global regenerative medicine market 2020 is touted to mature at the CAGR of about 25.4% over the review period (from 2016 to 2022).The global regenerative medicine industry is rapidly on the rise.Factors impacting the regenerative medicine industry are growing development in healthcare technologies, Growing the prevalence of chronic disorders and growing advances in stem cell science are driving market expansion.ALSO READ : turn, the rising prevalence of degenerative diseases and a lack of transplantation organs are projected to fuel business demand.Market development has been fuelled by the influential ability of regenerative medicine to remove, restore, and rebuild weakened tissues and organs.In addition, the use of nanomaterials in wound treatment, medication delivery, and immunomodulation has sparked development opportunities for the demand for regenerative medicines.
The expanding role of radiology, radiotherapy, and nuclear medicine in diagnostics and therapeutics is a case in point.Over the years, physicists have been increasingly leaning on discovering processes, procedures, and technologies, that will expand the scope and relevance of healthcare applications.These efforts reinforce the growing outlook of the medical physics market.Request a PDF Brochure - Physics Market: Competitive Analysis and Key DevelopmentsIn recent years, medical physicists are being exhorted to improve their contribution to healthcare systems world over.Experts believe that Medical Physics 3.0 (MP3.0) is likely to set the pace for sustainable excellence in medical physics, my maximizing the contribution of physicists to improvement of human health.Over the past few years, the medical physics market has been replete with mergers and acquisitions among the healthcare system manufacturers and healthcare providers.These include mammography systems, X-ray systems, computed tomography, magnetic resonance imaging, SPECT, and PET.Key end users include hospitals, academic and research institutes, ambulatory surgery centers, and diagnostic imaging centers.The need for reducing radiation toxicity in tomotherapy and intensity modulation radiotherapy (IMRT) is boosting the medical physics market.In coming years, future slew of investments in the medical physics market include orthopedics, ophthalmology, medical photonics, surgery, radiogenomics, nano?medicine, dentistry, vascular medicine, and neuro?science.Request for Analysis of COVID19 Impact on Medical Physics Market - Physics Market: Regional AnalysisOn the regional front, North America and Europe have been vastly attractive medical physics markets.
Global Oligonucleotide Therapeutics Market: OverviewOligonucleotides refer to short chain DNA or RNA that are generally made by using automated synthesizers.In addition, synthesis of siRNA duplex oligonucleotide is done through an annealing step in which two purified strands of oligonucleotide are brought closer together in an equimolar ratio.This factor results in the development of brand new oligonucleotides targeting certain genes and treating chronic diseases.The developed artificial oligonucleotides come with better enhanced affinity and in-vivo stability to target mRNA.These factors are likely to act as growth factors for the global oligonucleotide therapeutics market.Technology, application, and region are the three important parameters based on which the global oligonucleotide therapeutics market has been classified.Request a PDF Brochure - Oligonucleotide Therapeutics Market: Notable DevelopmentsThe global oligonucleotide therapeutics market is marked with presence of quite a few prominent players, thereby making it a fairly competitive market for both the existing players and new entrants.The following development is expected to play an important role in the market:In Dec 2016, US-based Biogen LLC obtained nod from US Food and Drug Administration (FDA) for nusinersen’s new drug application.
Oligonucleotide API Market: OverviewPharmaceutical companies have harnessed oligonucleotide active pharmaceutical ingredients (APIs) popularly in solid solutions (powdered form) and recently in solution form.The drive for the oligonucleotide API market stems from the vast utilization of oligonucleotides in treating a wide range of diseases.Some of the factors that have boosted the trend of oligonucleotide APIs in solution are solution stability, viscosity, concentration, end-to-end manufacturing, and packaging.Progress made in industry associations sharing of CMC (chemistry, manufacturing, and control) strategies is boosting the prospect in the oligonucleotide APIs market.Over the past 10 – 15 years, pharma companies have benefitted from the industry trend toward harmonization of oligonucleotide development and their commercialization.A growing body of science-based recommendations has paved way to development of oligonucleotide therapeutics.Rise in research in biologic therapeutics has strengthened the drug pipeline of pharma companies in the oligonucleotide APIs market.The market stakeholders have benefited from a comparative study on solution versus powder API.
Market Statistic, LLP has recently published a research study about Global Dermatology Therapeutics Market.The report illustrates the market thoroughly and has offer a structural evaluation analysis of the market.It showcases the graphical representations of the global Dermatology Therapeutics Market.‘Global Dermatology Therapeutics Market comprises of basic market dynamics like the driving and restraining factors, industry trends and growth opportunities in the forecast period (2021-2027).’ The report offers detailed analysis & statistics of the different market segments globally.Get sample pages from this research report @ The leading market players covered in this report are: •Genesis Biosystems•Inc•Cutera•Inc.•Cynosure•Inc•Alma Lasers•Ltd•Canfield•Solta Medical•Inc.•Michelson Diagnostics•HEINE Optotechnik GmbH & Co. KG•ICON plc•3Gens The scope of all these distinct segments has been covered in the report and has been researched separately.This is likely to help investors decide where to invest in the right industry segment.
On the basis of type the market is divided intoprocess oils, hydraulic fluids, gear lubricants, compressor lubricants, turbine lubricants, metalworking fluids, industrial engine oils, and others.They are helpful in enhancing abrasion & rolling resistance of tires.The segment is projected to grow at a CAGR of 3.52% to reach USD 53.7 million by the end of 2023.General industrial oils such as gear lubricants, turbine lubricants, and compressor lubricants are set to witness moderate growth over the forecast period.ALSO READ : Based on application, the Poland Industrial Lubricants Market is segmented as automotive manufacturing, power generation, process industry, food & beverages, mining, rail, construction, and others.Construction sector accounted for the largest market share of over 20% in 2016 and is set to grow at an estimated CAGR of 3.45% from 2017 to 2023.ALSO READ : generation is expected to witness the highest revenue CAGR of 3.55% from 2017 to 2023.
While this medical condition cannot be reversed, medications and injections have been found to be effective in the reducing the pain caused due to osteoarthritis.Drugs such as NSAIDs, analgesics, corticosteroids, and viscosupplement agents are being used widely to manage osteoarthritis.Global Leaders:The osteoarthritis therapeutics market is a highly fragmented market and has presence of various players.The major players operating in this market are Sanofi (France), Horizon Therapeutics PLC (Ireland), Johnson & Johnson (US), GlaxoSmithKline PLC (UK), Bayer AG (Germany), Abbott (US), Pfizer, Inc. (US), Eli Lilly (US), Anika Therapeutics, Inc. (US), Novartis AG (Switzerland), Ferring Pharmaceuticals (Switzerland), Bioventus (US), Zimmer Biomet Holdings, Inc. (US), Fidia Farmaceutici s.p.a. (Italy), Flexion Therapeutics, Inc. (US), Pharmed Limited (India), Virchow Biotech (India), Kitov Pharmaceuticals Ltd. (Israel), Assertio Therapeutics, Inc. (US), Atnahs (UK), Almatica Pharma LLC (US), OrthogenRx (US), LABRHA (France), Hanmi Pharm.Co., Ltd. (Korea), and Laboratorio Reig Jofre (Spain).Download PDF [email protected]:// Revenue Growth:The osteoarthritis therapeutics market is projected to reach USD 11.0 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 8.7% from 2020 to 2025.Major Growth BoostersThe growth of this market is driven by significant adoption of pain medications, increasing prevalence of osteoarthritis, growing population susceptible to osteoarthritis, and rising number of sports injuries.Sanofi (France)Sanofi held the leading position in the global viscosupplementation agents market in 2019.In 2019, it invested USD 6.74 billion in R, which consisted of 16.7% of the company revenue.The company offers viscosupplement-based injections for the treatment of osteoarthritis.